News

Tarceva is prescribed for patients with advanced-stage non-small cell lung cancer (NSCLC) whose cancer has not spread or grown after initial treatment with certain types of chemotherapy (maintenance

The company said that with the completion of the certification process the providers will be able to use its EHR to successfully demonstrate meaningful use and qualify for

Operating in Craigavon and Pennsylvania, the fully automated machines will reduce timelines associated with the use of blister card packaging, when compared with current rotary press methods. The

Reviewers from both agencies will separately assess the quality/chemistry, manufacturing and control (CMC) section of the new drug applications (NDAs) submitted to the FDA and marketing authorization applications

Victoza works by stimulating the release of insulin from the pancreatic beta cells only when blood sugar levels are high. Victoza is the brand name for liraglutide, the

The FORTIS-M Phase III trial is investigating Talactoferrin plus best supportive care compared to placebo plus best supportive care in patients with non-small cell lung cancer (NSCLC) whose

The tie up allows Envoy to use MBL’s RIP-Chip technology for its drug discovery and development purpose. Under the agreement, Envoy is responsible to pay an upfront payment,

Seattle Genetics entered into this collaboration with Millennium in April 2009, at which time Millennium has obtained an exclusive ADC license to an initial antigen expressed on solid

Patient enrollment is expected to be completed in the first half of 2011 and the company expects to report top-line results before year end. Unigene is developing its